Overview

Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly

Status:
Completed
Trial end date:
2003-01-03
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effectiveness of lanreotide autogel to placebo after a single injection. Effectiveness and safety were then also assessed following four fixed-dose injections and after one year of treatment given at titrated doses.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Ipsen
Treatments:
Angiopeptin
Lanreotide
Somatostatin